These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Roghani M, Baluchnejadmojarad T. Vascul Pharmacol; 2009 Nov 07; 51(2-3):84-9. PubMed ID: 19393342 [Abstract] [Full Text] [Related]
10. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition. Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA. Exp Eye Res; 1993 Dec 07; 57(6):723-35. PubMed ID: 8150024 [Abstract] [Full Text] [Related]
11. A new approach against sugar cataract through aldose reductase inhibitors. Banditelli S, Boldrini E, Vilardo PG, Cecconi I, Cappiello M, Dal Monte M, Marini I, Del Corso A, Mura U. Exp Eye Res; 1999 Nov 07; 69(5):533-8. PubMed ID: 10548473 [Abstract] [Full Text] [Related]
12. Influence of insulin on the microvascular response to inflammatory mediators in neonatal streptozotocin diabetic rats. Rastelli VM, Akamine EH, Oliveira MA, Nigro D, Passaglia Rde C, Carvalho MH, Fortes ZB. Inflamm Res; 2005 Apr 07; 54(4):173-9. PubMed ID: 15883740 [Abstract] [Full Text] [Related]
13. The beneficial in vitro effects of lovastatin and chelerythrine on relaxatory response to acetylcholine in the perfused mesentric bed isolated from diabetic rats. Fatehi-Hassanabad Z, Imen-Shahidi M, Fatehi M, Farrokhfall K, Parsaeei H. Eur J Pharmacol; 2006 Mar 27; 535(1-3):228-33. PubMed ID: 16516190 [Abstract] [Full Text] [Related]
14. Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy. Berkowitz BA, Ito Y, Kern TS, McDonald C, Hawkins R. Invest Ophthalmol Vis Sci; 2001 Nov 27; 42(12):2964-9. PubMed ID: 11687543 [Abstract] [Full Text] [Related]
15. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats. Kador PF, Inoue J, Secchi EF, Lizak MJ, Rodriguez L, Mori K, Greentree W, Blessing K, Lackner PA, Sato S. Exp Eye Res; 1998 Aug 27; 67(2):203-8. PubMed ID: 9733586 [Abstract] [Full Text] [Related]
16. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs. Datiles MB, Kador PF, Kashima K, Kinoshita JH, Sinha A. Invest Ophthalmol Vis Sci; 1990 Nov 27; 31(11):2201-4. PubMed ID: 2122961 [Abstract] [Full Text] [Related]
17. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Sun W, Oates PJ, Coutcher JB, Gerhardinger C, Lorenzi M. Diabetes; 2006 Oct 27; 55(10):2757-62. PubMed ID: 17003340 [Abstract] [Full Text] [Related]
18. The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. Stevens MJ, Dananberg J, Feldman EL, Lattimer SA, Kamijo M, Thomas TP, Shindo H, Sima AA, Greene DA. J Clin Invest; 1994 Aug 27; 94(2):853-9. PubMed ID: 8040341 [Abstract] [Full Text] [Related]
19. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats. Kojima K, Matsubara H, Harada T, Mizuno K, Suzuki M, Hotta N, Kakuta H, Sakamoto N. Jpn J Ophthalmol; 1985 Aug 27; 29(1):99-109. PubMed ID: 3159927 [Abstract] [Full Text] [Related]
20. Effects of chronic exercise on endothelial dysfunction and insulin signaling of cutaneous microvascular in streptozotocin-induced diabetic rats. Heidarianpour A, Hajizadeh S, Khoshbaten A, Niaki AG, Bigdili MR, Pourkhalili K. Eur J Cardiovasc Prev Rehabil; 2007 Dec 27; 14(6):746-52. PubMed ID: 18043294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]